Sponsor
Centre Jean Perrin
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Centre Jean Perrin appears in 35 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
35 shownAugmented Reality Feasibility for Non-invasive Preoperative Tracking in Breast Cancer SurgeryNCT06512558 · lead sponsor · 2024-11-14
RECRUITINGIntrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate CancerNCT06600802 · lead sponsor · 2024-10-08
RECRUITINGXenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast CancerNCT04133077 · lead sponsor · 2021-11-19
RECRUITINGFunctional Imaging of Digital Osteoarthritis and Rheumatoid Arthritis Using 99mTc-NTP 15-5 in Nuclear MedicineNCT07624994 · lead sponsor · 2026-08-01
NOT_YET_RECRUITINGSupport and Post-therapeutic Rehabilitation for Women in Complete Remission of Breast Cancer in a Thermal EnvironmentNCT05433077 · lead sponsor · 2022-06-27
ACTIVE_NOT_RECRUITINGInterest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer ScreeningNCT04273542 · lead sponsor · 2021-05-31
ACTIVE_NOT_RECRUITINGBreast Localization: RFID Tags vs Wire LocalizationNCT04750889 · lead sponsor · 2021-05-15
COMPLETEDEvaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer PatientsNCT04438681 · lead sponsor · 2020-11-27
ACTIVE_NOT_RECRUITINGAssessment of 99mTc-NTP 15-5 Uptake on Cartilage, a New Proteoglycan TracerNCT04481230 · lead sponsor · 2020-11-12
COMPLETEDCorrelation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer PatientsNCT04068623 · lead sponsor · 2019-12-04
ACTIVE_NOT_RECRUITINGLoreline Study: Characterization of Long Responders Under EribulineNCT03771183 · lead sponsor · 2019-08-23
COMPLETEDSatisfaction Assessment of Patients With Local Breast Cancer When Using Cosmetics During Chemotherapy and Post-treatment Thermal CureNCT03684135 · lead sponsor · 2018-08-03
COMPLETEDAdapted Physical Activity for Breast Cancer HER2 Positive PatientNCT02963363 · lead sponsor · 2018-04-27
TERMINATEDAssessment of the Impact of RNA Genomic Profile on Treatment Decision-making in HER2 Equivocal Breast Cancer PatientsNCT03197805 · lead sponsor · 2017-10-16
TERMINATEDMicrobiota and the Lung CancerNCT03068663 · lead sponsor · 2017-05-23
ACTIVE_NOT_RECRUITINGEffects of Preoperative Rehabilitation in Patients Resected for Lung CancerNCT03020251 · lead sponsor · 2017-05-12
COMPLETEDImpact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC RiskNCT02705924 · lead sponsor · 2016-04-01
TERMINATEDStudy of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2)NCT02509871 · lead sponsor · 2015-07-01
COMPLETEDAdaptated Physical Activity in CancerologyNCT02252991 · lead sponsor · 2014-09-01
TERMINATEDImpact of Chemo-induced Menopause on Quality of Life in Women <45 Years Old, Diagnosed With Non-metastatic Breast CancerNCT02102568 · lead sponsor · 2014-04-01
COMPLETEDMulticenter Study Comparing Taxotere Plus Curcumin Versus Taxotere Plus Placebo Combination in First-line Treatment of Prostate Cancer Metastatic Castration Resistant (CURTAXEL)NCT02095717 · lead sponsor · 2014-03-01
TERMINATEDPhase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and TaxanesNCT01910870 · lead sponsor · 2013-07-01
TERMINATEDPhase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and TaxanesNCT01910844 · lead sponsor · 2013-07-01
TERMINATEDContribution of MRI in the Evaluation of Apparent Diffusion Coefficient and Prediction of Response to Neoadjuvant Chemotherapy in Breast CancerNCT01956513 · lead sponsor · 2012-03-01
WITHDRAWNEtude Tomos- Apport de la Tomosynthèse Dans le Bilan d'Extension locorégional préthérapeutique d'Une Tumeur du Sein : Recherche de multicentricité Tomos Study- Contribution of Tomosynthesis In Locoregional Pretherapeutic Staging of a Breast Tumor: Multicentricity SearchNCT01522300 · lead sponsor · 2012-01-01
TERMINATEDEducational Intervention to Adherence of Patients Treated by Capecitabine +/- LapatinibNCT01847599 · lead sponsor · 2011-09-06
TERMINATEDWeight Variation During Chemotherapy in Breast Cancer PatientsNCT01506466 · lead sponsor · 2011-09-01
COMPLETEDAssessment of the Efficacy of the Neoadjuvant Combination: "Chemotherapy-Targeted Therapy" in Breast Cancer.NCT00933517 · lead sponsor · 2009-09-01
COMPLETEDDocetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate CancerNCT01012141 · lead sponsor · 2009-09-01
COMPLETEDDocetaxel With or Without a Phytochemical in Treating Patients With Breast CancerNCT00852332 · lead sponsor · 2009-08-01
TERMINATEDSupport and Rehabilitation Protocol for Non Metastatic Breast Cancer Patients in Complete Remission After ChemotherapyNCT01563588 · lead sponsor · 2008-12-01
TERMINATEDAssessment of the Efficacy of a Neoadjuvant Combination: "Chemotherapy-targeted Therapy" in Breast Cancer.NCT00600249 · lead sponsor · 2008-01-01
COMPLETEDBreast Cancer Treated by Neoadjuvant ChemotherapyNCT00425516 · lead sponsor · 2007-01-01
COMPLETEDStudying Biopsy Samples in Women Undergoing First-Line Chemotherapy for Metastatic Breast CancerNCT00870168 · lead sponsor · 2006-01-01
COMPLETEDCEPPPIA Pilot. Experimental Center of Participative and Individualized Predictive Prevention in AuvergneNCT03378895 · collaborator · 2017-12-01
COMPLETEDSponsor roles
lead sponsor34
collaborator1
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.